Stock Ratings / Health Care / INDV / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Indivior Pharmaceuticals Inc. (INDV) 12-Month Stock Forecast & Price Target Cone

$35.25 +1.38% NASDAQ • Public Delayed / 60s Snapshot

Indivior Pharmaceuticals Inc. (INDV) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (62/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+340.0% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D • SELL / AVOID Cap $4.16B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+1.8% Base Target

WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($2.5M)

44% PutsMax Pain: $35.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your INDV Position Size: $10,000

Shares at $35.25: 283.7 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $27.99

$7,940

$-2,060 (-20.6%)

12M Consensus BaseTarget $35.88

$10,179

+$179 (+1.8%)

12M Bull Case BreakoutTarget $44.95

$12,752

+$2,752 (+27.5%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$37	74%	A
Goldman SachsSector Coverage Lead	BUY	$42	69%	B
JP MorganUS Large-Cap Research	HOLD	$32	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring INDV)

✓Live walkthrough of INDV's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

INDV // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -3.83%⚡ TESTING RESISTANCE

2026-10-30O $34.78H $36.49L $34.62C $35.37VOL 4.61M

RES: $36.13SUP: $32.30SMA50: $35.20SMA200: $35.67

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

INDV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 INDV Butterfly Map → + Track INDV →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

13.3%/yr Implied 5Y Growth

vs. +4.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on INDV today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for INDV. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for INDV today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

INDV Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is INDV's 12-month stock price target?

Indivior Pharmaceuticals Inc. (INDV) carries a 12-month consensus base price target of $35.88 (+1.8% from $35.25), with a bull-case target of $44.95 and a bear-case floor of $27.99.

Is INDV stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates INDV D (Sell — SELL) with an RQD Confidence score of 62/100.

Direct Sub-Reports: INDV RQD Cockpit INDV 12M Forecast INDV Earnings & Move INDV Dividends & DRIP INDV Insiders & 13F INDV Whale Options INDV Profit Sankey INDV News & Why